Literature DB >> 24163428

Action of GH on skeletal muscle function: molecular and metabolic mechanisms.

Viral Chikani1, Ken K Y Ho.   

Abstract

Skeletal muscle is a target tissue of GH. Based on its anabolic properties, it is widely accepted that GH enhances muscle performance in sports and muscle function in the elderly. This paper critically reviews information on the effects of GH on muscle function covering structure, protein metabolism, the role of IGF1 mediation, bioenergetics and performance drawn from molecular, cellular and physiological studies on animals and humans. GH increases muscle strength by enhancing muscle mass without affecting contractile force or fibre composition type. GH stimulates whole-body protein accretion with protein synthesis occurring in muscular and extra-muscular sites. The energy required to power muscle function is derived from a continuum of anaerobic and aerobic sources. Molecular and functional studies provide evidence that GH stimulates the anaerobic and suppresses the aerobic energy system, in turn affecting power-based functional measures in a time-dependent manner. GH exerts complex multi-system effects on skeletal muscle function in part mediated by the IGF system.

Entities:  

Keywords:  growth hormone; metabolism; muscle; power; strength

Mesh:

Substances:

Year:  2013        PMID: 24163428     DOI: 10.1530/JME-13-0208

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  31 in total

Review 1.  Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects.

Authors:  Lindsey J Anderson; Jamie M Tamayose; Jose M Garcia
Journal:  Mol Cell Endocrinol       Date:  2017-06-09       Impact factor: 4.102

2.  Growth Hormone Induces Colon DNA Damage Independent of IGF-1.

Authors:  Vera Chesnokova; Svetlana Zonis; Robert J Barrett; John P Gleeson; Shlomo Melmed
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

3.  Excess growth hormone suppresses DNA damage repair in epithelial cells.

Authors:  Vera Chesnokova; Svetlana Zonis; Robert Barrett; Hiraku Kameda; Kolja Wawrowsky; Anat Ben-Shlomo; Masaaki Yamamoto; John Gleeson; Catherine Bresee; Vera Gorbunova; Shlomo Melmed
Journal:  JCI Insight       Date:  2019-02-07

4.  Influence of Disease Activity and Body Composition Parameters on Cross-Sectional Area of the Median Nerve in Acromegalic Patients.

Authors:  I Ságová; D Pavai; D Kantárová; D Holováčová; M Kužma; J Payer; P Vaňuga
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

Review 5.  Growth Hormone and Insulin-Like Growth Factor 1 Regulation of Nonalcoholic Fatty Liver Disease.

Authors:  Laura E Dichtel; Jose Cordoba-Chacon; Rhonda D Kineman
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

6.  Body Composition, IGF1 Status, and Physical Functionality in Nonagenarians: Implications for Osteosarcopenia.

Authors:  Eleonora Poggiogalle; Katie E Cherry; L Joseph Su; Sangkyu Kim; Leann Myers; David A Welsh; S Michal Jazwinski; Eric Ravussin
Journal:  J Am Med Dir Assoc       Date:  2018-08-24       Impact factor: 4.669

Review 7.  Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role?

Authors:  Nabanita S Datta
Journal:  Endocrine       Date:  2014-05-07       Impact factor: 3.633

8.  Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles.

Authors:  Edward O List; Darlene E Berryman; Kevin Funk; Adam Jara; Bruce Kelder; Feiya Wang; Michael B Stout; Xu Zhi; Liou Sun; Thomas A White; Nathan K LeBrasseur; Tamara Pirtskhalava; Tamara Tchkonia; Elizabeth A Jensen; Wenjuan Zhang; Michal M Masternak; James L Kirkland; Richard A Miller; Andrzej Bartke; John J Kopchick
Journal:  Endocrinology       Date:  2014-02-11       Impact factor: 4.736

9.  Adult individuals with congenital, untreated, severe isolated growth hormone deficiency have satisfactory muscular function.

Authors:  Alana L Andrade-Guimarães; Manuel H Aguiar-Oliveira; Roberto Salvatori; Vitor O Carvalho; Fabiano Alvim-Pereira; Carlos R Araújo Daniel; Giulliani A Moreira Brasileiro; Ananda A Santana-Ribeiro; Hugo A Santos-Carvalho; Carla R P Oliveira; Edgar R Vieira; Miburge B Gois-Junior
Journal:  Endocrine       Date:  2018-09-24       Impact factor: 3.633

10.  Dexamethasone and BCAA Failed to Modulate Muscle Mass and mTOR Signaling in GH-Deficient Rats.

Authors:  Hikaru Nishida; Ayaka Ikegami; Chiaki Kaneko; Hitomi Kakuma; Hisano Nishi; Noriko Tanaka; Michiko Aoyama; Makoto Usami; Yasuhiko Okimura
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.